The capabilities and experience in the discovery services have helped our clients accelerate their drug discovery programs. With a combination of 550 highly skilled scientists and a hi-tech set-up, we provide integrated chemistry services, including synthetic and medicinal chemistry, synthesis of a library of compounds from a few milligrams to a hundred-gram scale, or differentiated solutions for various drug discovery programs. We bring a track record of solving complex challenges across multiple therapeutic areas along with focused library search to fast-track discovery programs. The in-house capability to generate as well as procure proteins facilitate faster turn-around time for protein production.
Our Discovery Chemistry services extend from synthetic chemistry, library synthesis, peptide synthesis, PROTACs, and Oligonucleotides. The essential facilities at our centers provide the environment to generate and synthesize in-house, truncated proteins, and modified proteins that are not commercially available. The strong CADD team facilitates the hit identification by screening virtual libraries and is backed by strong analytical chemistry support, IT infrastructure, and competent data management systems.
With 40 modular labs including advanced analytical instruments, ranging from various synthesizers, NMR machines, and FT-IR, we provide the best-in-class medicinal chemistry services to various biotech, pharmaceutical, agrochemical, and specialty chemical companies.
With the advanced synthetic chemistry methodologies and innovative route scouting design technologies, we provide a multi-gram quantity of high purity compounds to support your research needs across the discovery cycle.
Our dedicated team of experts has a track record of handling peptides ranging from simple linear peptides to polypeptides synthesis and its very complex forms from milligram to multi-gram quantities for advancing your discovery and developmental research needs.
We have two decades of vast experience in working with global clients in custom library synthesis of compounds and generating small to medium-sized custom libraries of target compounds.
Expertise in the synthesis of PROTAC and partial PROTAC for targeted protein degradation, including the development and functionalization of various E3-ligase ligands such as CRBN, VHL, MDM2, and cIAP1, some of them even on the multi-gram scale.
We can synthesize 10-40-mer oligonucleotides up to 1 gram scale. We can perform all standard modifications, with or without backbone modification. We provide in-house capabilities for making any customized phosphoramidite.
Our highly experienced team of scientists perform various synthesis, characterization & biological evaluations of lipids ranging from 10 mg to 10 g scale.
The CADD/Bioinformatics teams at APSL work in tandem with chemistry and biology teams at every stage of the program. The CADD services facilitate the designing of molecules for various applications and aid in the discovery of new drugs with the help of advanced databases and software to support various projects.
90% of talent is PG or above
Integration of chemistry to biology & CDMO
State-of-the art facilities and modern infrastructure.
Data driven decision making- CADD, informatics, advanced software platforms
50K+ compound inventory management system
Integrated Services
Co-located Teams
20+ Years of legacy
Target identification to commercial manufacturing
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
JANUARY 04, 2021
Methoxy Polyethylene Glycols (mPEGs) are increasingly being applied in drug discovery and drug development to enhance the deliverability and bioavailability of the drug, and to increase the serum half-life. Today, due to advancements in chemical processes and purification techniques it is possible to produce high-quality mPEGs. mPEGs in combinati...
Read MoreAccelerating Drug Discovery Through Innovative Partnerships Genomics plays a vital role in identifying which gene is associated with a specific disease. A gene called CNOT1 is for example known for it's effect on brain development and for impairing memory and learning. Despite the great promise genomics provides in understanding the disease, gene...
Read MoreAurigene Pharmaceutical Services has decades of experience in providing services for peptide drug discovery, development and formulation manufacturing and is specialized in the synthesis of various types ...
Read MoreWe are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...
Read More2013
The combination of CuI–K2CO3-PEG 400 facilitated the couplingcyclization of o-iodobenzoic acid with terminal alkynes under ultrasound, affording a greener and practical approach towards 3-substituted isocoumarins with remarkable regioselectivity. This inexpensive and Pd and ligand free methodology gave rise to various isocoumarins of potential pharmacological i...
Read More2005
Synthesis of the anti-covid therapeutic Nirmatrelvir by using flow chemistry to enhance efficiency of amide to nitrile conversion in a functionally and Stereochemically Embellished environment. ...
Read More2005
Mutations in MEK1/2 have been described as a resistance mechanism to BRAF/MEK inhibitor treatment. We report the discovery of a novel ATP-competitive MEK1/2 inhibitor with efficacy in wildtype (WT) and mutant MEK12 models. Starting from a HTS hit, we obtained selective, cellularly active ...
Read More2005
The sulphonic acid-functionalized Wang resin (Wang-OSO3H) was explored as a polymeric and recov- erable acidic catalyst for the synthesis of isoindolo[2,1- a ]quinazoline-5,11–dione derivatives under green conditions. Thus the Wang-OSO3H ...
Read MoreYou are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market